These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 7018813)
1. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients. Millar JA; McGrath BP; Matthews PG; Johnston CI Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813 [TBL] [Abstract][Full Text] [Related]
2. Use of captopril in the diagnosis of renal hypertension. McGrath BP; Matthews PG; Johnston CI Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291 [TBL] [Abstract][Full Text] [Related]
4. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102 [TBL] [Abstract][Full Text] [Related]
5. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients. McGrath BP; Matthews PG; Johnston CI Clin Exp Pharmacol Physiol; 1980; 7(5):487-91. PubMed ID: 7004680 [TBL] [Abstract][Full Text] [Related]
6. Haemodynamic and humoral effects of lower body negative pressure in normal, sodium-replete man during angiotensin-converting enzyme inhibition with captopril. Rasmussen S; Hesse B; Bonde-Petersen F; Damkjaer Nielsen M; Christensen NJ; Giese J; Warberg J Scand J Clin Lab Invest; 1986 Feb; 46(1):81-8. PubMed ID: 3006218 [TBL] [Abstract][Full Text] [Related]
7. Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension. Koletsky RJ; Gordon MB; LeBoff MS; Moore TJ; Dluhy RG; Hollenberg NK; Williams GH Clin Sci (Lond); 1984 Mar; 66(3):299-305. PubMed ID: 6362960 [TBL] [Abstract][Full Text] [Related]
8. The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects. MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ Clin Sci (Lond); 1980 Dec; 59 Suppl 6():95s-99s. PubMed ID: 7004744 [TBL] [Abstract][Full Text] [Related]
9. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril. Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113 [TBL] [Abstract][Full Text] [Related]
10. Effect of inhibition of converting enzyme on inactive renin in the circulation of salt-replete and salt-deplete normal subjects. Millar JA; Hammat MT; Johnston CI J Endocrinol; 1980 Aug; 86(2):329-35. PubMed ID: 6253587 [TBL] [Abstract][Full Text] [Related]
11. Vasoactive peptides and hypertension: role of angiotensin converting enzyme. Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379 [TBL] [Abstract][Full Text] [Related]
12. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension. Matthews PG; McGrath BP; Johnston CI Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Johnston CI; Millar JA; McGrath BP; Matthews PG Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216 [TBL] [Abstract][Full Text] [Related]
14. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat. Marks ES; Bing RF; Thurston H; Swales JD Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224 [TBL] [Abstract][Full Text] [Related]
15. Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension. Morganti A; Sala C; Turolo L; Palermo A; Zanchetti A J Hypertens; 1985 Feb; 3(1):55-61. PubMed ID: 2987342 [TBL] [Abstract][Full Text] [Related]
16. [Antihypertensive mechanism of oral angiotensin I converting enzyme inhibitor (captopril) in renin-independent essential hypertension]. Miyamori I; Takeda Y; Ikeda M; Koshida H; Yasuhara S; Morise T; Takimoto H; Takeda R; Nishino T Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):907-17. PubMed ID: 6311635 [TBL] [Abstract][Full Text] [Related]
17. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system]. Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144 [TBL] [Abstract][Full Text] [Related]
18. Diuretic response to acute hypertension is blunted during angiotensin II clamp. Leong PK; Zhang Y; Yang LE; Holstein-Rathlou NH; McDonough AA Am J Physiol Regul Integr Comp Physiol; 2002 Oct; 283(4):R837-42. PubMed ID: 12228052 [TBL] [Abstract][Full Text] [Related]
19. Characterization of neurohormonal changes following the production of the benign and malignant phases of two-kidney, two-clip Goldblatt hypertension. Suzuki H; Saruta T; Ferrario CM; Brosnihan KB Jpn Heart J; 1987 May; 28(3):413-26. PubMed ID: 2887673 [TBL] [Abstract][Full Text] [Related]
20. Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats. Iyer SN; Averill DB; Chappell MC; Yamada K; Allred AJ; Ferrario CM Hypertension; 2000 Sep; 36(3):417-22. PubMed ID: 10988275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]